Darwin Global Management, Ltd. Quant / Systematic

CIK: 0001839209 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value ($000): $510,680 (100.0% shares, 0.0% debt)

Holdings (12)

— ACCELERON PHARMA INC 40.0%
Value ($000) $204,095 Shares 1,505,012 Est. Cost $130.83 Unrealized —
BBIO BRIDGEBIO PHARMA INC 25.2%
Value ($000) $128,753 Shares 2,090,149 Est. Cost $59.97 Unrealized +9.1%
FATE FATE THERAPEUTICS INC 22.1%
Value ($000) $112,967 Shares 1,370,133 Est. Cost $72.37 Unrealized +32.4%
RLAY RELAY THERAPEUTICS INC 5.3%
Value ($000) $27,050 Shares 782,471 Est. Cost $43.40 Unrealized 0.0%
ARVN ARVINAS INC 1.8%
Value ($000) $9,288 Shares 140,511 Est. Cost $65.97 Unrealized +16.0%
MGNX MACROGENICS INC 1.8%
Value ($000) $9,115 Shares 286,195 Est. Cost $24.28 Unrealized 0.0%
— GENERATION BIO CO 1.2%
Value ($000) $6,243 Shares 219,358 Est. Cost $28.36 Unrealized —
KROS KEROS THERAPEUTICS INC 1.0%
Value ($000) $5,348 Shares 86,887 Est. Cost $63.36 Unrealized 0.0%
CCCC C4 THERAPEUTICS INC 1.0%
Value ($000) $5,180 Shares 140,034 Est. Cost $29.00 Unrealized +37.2%
IMVT IMMUNOVANT INC 0.2%
Value ($000) $1,056 Shares 65,849 Est. Cost $46.23 Unrealized -43.0%
— INHIBRX INC 0.2%
Value ($000) $998 Shares 49,709 Est. Cost $29.56 Unrealized —
FULC FULCRUM THERAPEUTICS INC 0.1%
Value ($000) $587 Shares 49,868 Est. Cost $11.31 Unrealized +9.4%